Pfizer: Candidemia trials

The registry lists 15 Candidemia studies with Pfizer as lead sponsor. 0 are open to participants now and 13 have results posted.

Phase 2 2Phase 3 7Phase 4 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With EchinocandinsTerminatedNCT01213823Results posted
• Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United KingdomCompletedNCT01202253Results posted
• A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisTerminatedNCT01176058Phase 3Results posted
• A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy SubjectsCompletedNCT00940017Phase 4Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune SystemTerminatedNCT00806351Phase 3Results posted
• An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaTerminatedNCT00805740Phase 3Results posted
• Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IVCompletedNCT00802854Results posted
• Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisCompletedNCT00761267Phase 3Results posted
• Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal InfectionCompletedNCT00739934Phase 2Results posted
• Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedNCT00689338Phase 3Results posted
• This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedNCT00548262Phase 4Results posted
• Anidulafungin In Treatment Of Candidemia In Asian SubjectsCompletedNCT00537329Phase 3Results posted
• Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedNCT00496197Phase 4Results posted
• The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
• The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.CompletedNCT00037219Phase 2